×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [5]
中国医学科学院 北京... [4]
四川大学 [2]
北京大学 [1]
上海药物研究所 [1]
山东大学 [1]
更多...
内容类型
期刊论文 [13]
会议论文 [2]
发表日期
2020 [1]
2019 [2]
2018 [2]
2017 [4]
2015 [1]
2013 [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共15条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
提交时间升序
提交时间降序
题名升序
题名降序
作者升序
作者降序
A Concise and Efficient Approach to 2,6-Disubstituted 4-Fluoropyrimidines from alpha-CF3 Aryl Ketones
期刊论文
SYNTHESIS-STUTTGART, 2020, 卷号: 52, 期号: 2, 页码: 273-280
作者:
Liu, Fangran
;
Zhang, Xiaofei
;
Qian, Qun
;
Yang, Chunhao
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2020/07/01
fluoropyrimidine
alpha-CF3 aryl ketone
metal-free
mild conditions
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial
期刊论文
CANCER COMMUNICATIONS, 2019, 卷号: 39
作者:
Shi, Yuankai
;
Li, Jin
;
Xu, Jianming
;
Sun, Yan
;
Wang, Liwei
收藏
  |  
浏览/下载:112/0
  |  
提交时间:2019/12/05
CMAB009
Cetuximab
Irinotecan
Second-line
mCRC
EGFR
KRAS
Immunogenicity
Fluoropyrimidine
Oxaliplatin failure
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase I
期刊论文
2019, 卷号: 39, 期号: 1, 页码: 28
作者:
Shi, Yuankai
;
Li, Jin
;
Xu, Jianming
;
Sun, Yan
;
Wang, Liwei
收藏
  |  
浏览/下载:43/0
  |  
提交时间:2020/01/03
CMAB009
Cetuximab
Irinotecan
Second-line
mCRC
EGFR
KRAS
Immunogenicity
Fluoropyrimidine
Oxaliplatin failure
Relevance of MTHFR polymorphisms with response to fluoropyrimidine-based chemotherapy in oesophagogastric cancer: a meta-analysis.
期刊论文
BMJ open, 2018, 卷号: No.5, 页码: e020767
作者:
Zhong, L
;
Fu, Q
;
Zhou, S
;
Chen, L
;
Peng, Q
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/02/25
MTHFR
Oe sophagogastric cancer
chemotherapy response
fluoropyrimidine
polymorphism
Novel fluoropyrimidine-based chemotherapy for advanced well-differentiated neuroendocrine tumors: a clinical update
期刊论文
2018, 卷号: 19, 期号: 8, 页码: 795-807
作者:
Zhang, Heling
;
Shen, Guoshuang
;
Zhang, Shuisheng
;
Du, Feng
;
Cao, Yang
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2020/01/03
Chemotherapy
fluoropyrimidine
well-differentiated
neuroendocrine tumours
predictor
A phase III trial (ZJBIO009): CMAB009 plus irinotecan versus irinotecan alone as second-line treatment after fluoropyrimidine and oxaliplatin failure in wild-type K-ras metastatic colorectal cancer patients
期刊论文
Journal of Clinical Oncology, 2017, 卷号: 35
作者:
Shi Y., Li J., Xu J., Cheng Y., Liu W., Cheng Y., Bai L., Zhang Y., He X., Luo Y., Liu Y., Yao Q., Li Y., Qin S., Hu X., Guo Y., Sun Y.
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/12/05
Self-Assembly of an Amphiphilic Janus Camptothecin-Floxuridine Conjugate into Liposome-Like Nanocapsules for More Efficacious Combination Chemotherapy in Cancer
期刊论文
ADVANCED MATERIALS, 2017
Liang, Xiaolong
;
Gao, Chuang
;
Cui, Ligang
;
Wang, Shumin
;
Wang, Jinrui
;
Dai, Zhifei
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2017/12/03
cancer chemotherapy
coordinated release
drug-drug conjugates
Janus nanoparticles
self-assembly
STEALTH LIPOSOMES
DRUG-DELIVERY
IN-VIVO
THERAPY
TUMOR
NANOPARTICLES
IRINOTECAN
NANODRUG
RATIOS
A phase III trial (ZJBI0009): CMABOO9 plus irinotecan versus irinotecan alone as second-line treatment after fluoropyrimidine and oxaliplatin failure in wild-type K-ras metastatic colorectal cancer patients.
会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:
Shi, Yuankai
;
Li, Jin
;
Xu, Jianming
;
Cheng, Ying
;
Liu, Wei
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/04
A phase III trial (ZJBI0009): CMABOO9 plus irinotecan versus irinotecan alone as second-line treatment after fluoropyrimidine and oxaliplatin failure in wild-type K-ras metastatic colorectal cancer patients.
期刊论文
2017, 卷号: 35
作者:
Shi, Yuankai
;
Li, Jin
;
Xu, Jianming
;
Cheng, Ying
;
Liu, Wei
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/04
An updated meta-analysis and system review: Is gemcitabine+fluoropyrimidine in combination a better therapy versus gemcitabine alone for advanced and unresectable pancreatic cancer?
期刊论文
Asian Pacific Journal of Cancer Prevention, 2015, 卷号: 16, 期号: 14, 页码: 5681-5686
作者:
Tu C.
;
Zheng F.
;
Wang J.-Y.
;
Li Y.-Y.
;
Qian K.-Q.
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/17
Capecitabine
Fluorouracil
Gemcitabine
Meta-analysis
Pancreatic cancer
S-1
©版权所有 ©2017 CSpace - Powered by
CSpace